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Abstract 
Kawasaki disease is an acute febrile disease predominantly seen in young children. We 
report a case of Kawasaki disease in a 32-year-old pregnant woman. She developed a 
generalized erythematous skin rash accompanied by high fever. Bilateral conjunctival 
congestion, tender cervical lymphadenopathy, an edematous lower lip and peripheral 
edema followed by desquamation were observed. She was successfully treated with 
aspirin and intravenous gammaglobulin (1 g/kg/day). Her course was not complicated by 
coronary artery aneurysm and she delivered a healthy baby. To the best of our 
knowledge, this is the first case of Kawasaki disease in a pregnant woman. We suggest 
that Kawasaki disease should be included in the differential diagnosis of a generalized, 
erythematous skin rash accompanied by high fever in adults. 
Introduction 
Kawasaki disease (KD) was originally described by a Japanese pediatrician, Dr. 
Tomisaku Kawasaki, in 1967. It is an acute febrile illness occurring predominantly in 
young children. Here, we describe a case of KD in a 32-year-old pregnant woman. 
Case Report 
Our patient was a 32-year-old Japanese woman at 17 weeks of gestation, not multigravida, and 
without complications. She had presented with a headache and a low-grade fever. Her local obstetrician 
had diagnosed her with a common cold and had administered a 3-day course of amoxicillin. Seven days Case Rep Dermatol 2011;3:98–102 
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later, the patient developed a generalized skin rash accompanied by high fever (over 38°C) and was 
referred to the Department of Dermatology for further evaluation. 
On admission, physical examination revealed erythematous macules up to 1–2 cm in size covering 
almost the entire body (fig. 1). Some erythematous plaques had dusky centers that resembled the iris 
lesion of erythema multiforme (fig. 2). The patient’s temperature was 40.0°C. Her pulse was regular at 
130 beats/min and blood pressure was 110/60 mm Hg. Her palms and soles were edematous. Bilateral 
conjunctival congestion, tender cervical lymphadenopathy, and an edematous lower lip were also noted. 
Examination of the lungs, abdomen and neurologic system did not reveal any abnormal findings. 
Electrocardiogram and transthoracic echocardiogram were normal. Laboratory investigations revealed 
an elevated erythrocyte sedimentation rate and C-reactive protein (54.7 mm/h and 5.66 μg/dl, 
respectively), leukocytosis (12.05 × 10
9/l), and elevated liver enzymes including aspartate 
aminotransferase (78 U/l) and alanine aminotransferase (102 U/l). Ferritin was elevated at 1,479.2 
ng/ml. No eosinophilia was detected. Analysis of urine revealed 2+ protein, 20–30 white blood cells, and 
2+ of bacteria. Blood and urine cultures did not yield growth of pathogenic microorganism. Serological 
tests for hepatitis B and C, measles, rubella, Epstein-Barr virus, parvovirus B19, cytomegalovirus, 
Streptococcus, and Mycoplasma showed no evidence of a recent infection. Antinuclear antibodies and 
anti-neutrophil cytoplasmic antibodies were not detected. Histopathological examination of a skin 
biopsy showed focal spongiosis, scattered dyskeratotic cells and hydropic degeneration of the epidermis. 
Perivascular mononuclear lymphocytic infiltrates and extravasation of erythrocytes without vasculitis 
were also noted. 
The patient had features which fulfilled the 6 diagnostic criteria of KD [1] on admission, i.e. 
prolonged fever, conjunctival congestion, injected lip, generalized exanthema, cervical 
lymphadenopathy, and swollen hands and feet. Intravenous prednisolone (40 mg/d for 2 days) and 
imipenem/cilastatin (1 g/d for 3 days) were started, because a bacterial infection or a drug allergy could 
not be completely excluded. The patient did not respond to these treatments and the high fever 
remained. Administration of intravenous gammaglobulin (1 g/kg/day, given once) and oral aspirin (660 
mg daily) were started under the presumptive diagnosis of KD. The symptoms dramatically improved 
over the next 48 h, resulting in cessation of the fever and reduction of the erythematous rash, and the 
daily dosage of aspirin was subsequently reduced to 162 mg. After 10 days of hospitalization, the 
patient’s fingertips began to desquamate. The clinical course and laboratory findings are summarized in 
fig. 3. Serial transthoracic echocardiograms showed no evidence of coronary artery aneurysm (CAA). 
At 40 weeks of gestation, the patient spontaneously delivered a viable infant with Apgar scores of 8 at 1 
min and 9 at 5 min. Her postpartum course was uncomplicated and her child remained healthy. 
Discussion 
In 1967, based on a series of 50 Japanese children, Kawasaki described a unique 
disorder characterized by fever, generalized rash, conjunctival congestion, cervical 
lymphadenopathy, inflammation of the lips and oral cavity, and redness and swelling of 
the hands and feet [2]. Although this disorder was originally referred to as 
‘mucocutaneous lymph node syndrome’, the condition is nowadays referred to as KD. KD 
predominantly affects infants and young children and rarely occurs in adults [4, 5]. In the 
literature, to the best of our knowledge, there have been 81 reported adult cases of 
classical (complete) KD [5]. Because of the lack of specific laboratory findings, the 
diagnosis depends on clinical criteria, which are classified as principal and other minor 
clinical/laboratory findings. The principal findings are: (1) fever lasting for at least 5 days; 
(2) peripheral extremity findings, such as peripheral edema, peripheral erythema, and 
desquamation; (3) a polymorphic exanthema; (4) bilateral conjunctival injection; (5) oral 
mucous membrane findings, such as injected pharynx, injected lips, and strawberry 
tongue; and (6) acute non-suppurative swelling of the cervical lymph nodes [1]. The 
presence of at least 5 of these principal findings establishes the diagnosis, but the presence Case Rep Dermatol 2011;3:98–102 
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of 4 is accepted, if the patient has evidence of CAA. Our patient had all 6 principal 
findings. 
Because KD is rarely encountered in adolescents or adults, the diagnosis in these age 
groups is occasionally problematic. Differences in clinical manifestations, laboratory 
findings, and therapeutic response between adult and pediatric KD cases have not been 
fully investigated. A literature review by Jackson et al. [3] in 1994 revealed that adult 
patients with an age range of 18–68 years had various types of exanthema, described as a 
diffuse erythematous, macular, maculopapular, or scarlatiniform rash. Comparison of the 
clinical features of adult and pediatric KD showed that lymphadenopathy, arthralgia, and 
liver dysfunction occur more frequently in adults (93, 61, and 65% of adult cases, 
respectively) than in children (15, 24–38, and 10% of cases, respectively) [4]. On
 the 
contrary, CAAs are less common in adults (5–7%) than in children (20%). However, this 
may reflect the difficulty in visualizing the adult coronary vasculature using transthoracic 
echocardiography [4]. 
Although the pathogenesis of KD remains unknown, epidemiologic features and 
clinical presentations suggest an infectious etiology. Marked immune perturbations, 
including stimulation of cytokine cascade, occur during the acute phase of KD. Among 
the various cytokines, tumor necrosis factor-alpha (TNF-α) seems to play an essential role 
in the vascular injury of KD [6]. TNF-α activates nuclear factor kappa B (NF-κB), a 
pivotal transcription factor for the genes of proinflammatory cytokines, chemokines and 
adhesion molecules [7]. NF-κB is also activated by numerous stimuli such as bacterial 
lipopolysaccharide endotoxin, reactive oxygen species and various cytokines. Kraus et al. 
[8] found that serum TNF-α level is increased throughout gestation. Ross et al. [9] showed 
activation of NF-κB during the swine estrous cycle and specifically in the initial phase of 
pregnancy. This suggests that pregnancy might also affect the pathophysiology of KD. 
Two cases of KD in postpartum women have been reported [10, 11]. Infantile KD cases 
accompanied by coronary artery lesions may become pregnant after growing up as well 
[12, 13]. However, to the best of our knowledge, our patient is the first case with acute 
onset of KD in a pregnant woman in the literature. 
Intravenous immunoglobulin (IVIG) and oral aspirin have been used for treatment of 
KD. IVIG is usually administered as a single infusion of 2 g/kg (high-dose IVIG) in 
children [14]. Although previous reports showed a clinical benefit in adults with KD 
receiving IVIG, there has been no randomized controlled study evaluating the optimal 
dose or timing of IVIG therapy in adults. Some clinical studies have shown that either a 
single dose or 2 infusions of IVIG at 1 g/kg (medium-dose IVIG) was equally effective 
[15]. In our case, a single infusion of medium-dose IVIG achieved a satisfactory 
improvement. It has been reported that anti-TNF agents are useful for KD patients who 
failed to respond to IVIG treatment [16]. 
Recently, the term ‘atypical’ or ‘incomplete’ KD has been proposed to denote cases that 
do not fulfill the classical criteria of KD. Recently, Gomard-Mennesson et al. [5] described 
10 cases of adult KD, 6 of which did not fulfill the classical KD criteria. Therefore, KD 
might not always be recognized in adults. A literature review by Sève et al. [4] revealed 
that the clinical features and sequelae of KD are similar in adults and children, but adults 
have a more favorable prognosis because of a lower incidence of CAA. Our case suggests Case Rep Dermatol 2011;3:98–102 
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that KD needs to be considered in adults – including pregnant women – with a protracted 
high fever and a generalized skin rash because of the potential risk of CAA. 
 
 
Fig. 1. Confluent, erythematous macules covering almost the entire body. 
 
 
 
Fig. 2. Erythematous plaques with dusky centers. 
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Fig. 3. Clinical course of the present case. IPM =Imipenem; CS = cilastatin. 
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